Data / Drug companies / Zhejiang Ausun Pharmaceutical Co., Ltd.
Zhejiang Ausun Pharmaceutical Co., Ltd.: 58 products in the FDA NDC directory, labeler code 76397
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Zhejiang Ausun Pharmaceutical Co., Ltd. (labeler code 76397) lists 58 products in the FDA National Drug Code Directory. By type: 58 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 29, 2026.
The request: Watch Zhejiang Ausun Pharmaceutical Co., Ltd. (FDA labeler code 76397): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 76397
- Products in commercial distribution
- 58
- Packages
- 155
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 16
- Earliest marketing start
- February 22, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 48 | 82.8% |
| Bulk ingredients for compounding | 10 | 17.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 58 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 55 | 94.8% |
| Oil | 2 | 3.4% |
| Liquid | 1 | 1.7% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Perfluorohexyloctane | 76397-064 | Powder | Bulk ingredients | September 29, 2026 |
| Cabozantinib (s)-malate | 76397-063 | Powder | Bulk ingredients | September 29, 2026 |
| Ibrutinib | 76397-062 | Powder | Bulk ingredients | September 29, 2026 |
| Ivacaftor | 76397-061 | Powder | Bulk ingredients | August 12, 2026 |
| Dapagliflozin | 76397-060 | Powder | Bulk ingredients | July 27, 2026 |
| Dapagliflozin | 76397-059 | Powder | Bulk ingredients | July 27, 2026 |
| Efinaconazole | 76397-058 | Powder | Bulk ingredients | July 14, 2026 |
| Tofacitinib citrate | 76397-057 | Powder | Bulk ingredients | May 27, 2026 |
| Alectinib hydrochloride | 76397-055 | Powder | Bulk ingredients | April 22, 2026 |
| Pilocarpine hydrochloride | 76397-054 | Powder | Bulk ingredients | April 22, 2026 |
| Maralixibat chloride | 76397-053 | Powder | Bulk ingredients | April 20, 2026 |
| Ibrutinib | 76397-052 | Powder | Bulk ingredients | April 7, 2026 |
| Latanoprost | 76397-051 | Liquid | Bulk ingredients | December 3, 2025 |
| Ramelteon | 76397-050 | Powder | Bulk ingredients | November 27, 2025 |
| Palbociclib | 76397-049 | Powder | Bulk ingredients | November 24, 2025 |
| Palbociclib | 76397-048 | Powder | Bulk ingredients | November 24, 2025 |
| Lumateperone tosylate | 76397-047 | Powder | Bulk ingredients | September 16, 2025 |
| Imatinib mesylate | 76397-046 | Powder | Bulk ingredients | August 25, 2025 |
| Ruxolitinib phosphate | 76397-045 | Powder | Bulk ingredients | June 27, 2025 |
| Macitentan | 76397-044 | Powder | Bulk ingredients | April 27, 2025 |
| Olaparib | 76397-043 | Powder | Bulk ingredients | April 27, 2025 |
| Lenvatinib besylate | 76397-042 | Powder | Bulk ingredients | April 27, 2025 |
| Avatrombopag maleate | 76397-041 | Powder | Bulk ingredients | March 17, 2025 |
| Maralixibat chloride | 76397-040 | Powder | Bulk ingredients | March 17, 2025 |
| Avatrombopag maleate | 76397-038 | Powder | Bulk ingredients | October 27, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.